Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2019 Filed Jun 17, 2019 20:30 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 94 | $110.58 | $10,394.52 |
DisclosureSEC source: 0000899243-19-017191 · doc4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,789 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:29 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 231 | $109.37 | $25,264.47 |
DisclosureSEC source: 0001127602-19-021561 · form4.xml · nonDerivative · entry 1 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,138 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:27 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 190 | $109.37 | $20,780.30 |
DisclosureSEC source: 0001127602-19-021560 · form4.xml · nonDerivative · entry 1 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,460 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:35 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 39 | $109.37 | $4,265.43 |
DisclosureSEC source: 0001127602-19-021564 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,883 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:33 UTC |
Bolorforosh SaidEVP, Chief Technology Officer
|
SaleCommon Stock | 69 | $109.37 | $7,546.53 |
DisclosureSEC source: 0001127602-19-021563 · form4.xml · nonDerivative · entry 1 Bolorforosh Said · CIK 0001741776 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,141 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:31 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 108 | $109.37 | $11,811.96 |
DisclosureSEC source: 0001127602-19-021562 · form4.xml · nonDerivative · entry 1 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,674 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:25 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 1,248 | $109.37 | $136,493.76 |
DisclosureSEC source: 0001127602-19-021559 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,151 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:19 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 192 | $104.38 | $20,040.96 |
DisclosureSEC source: 0001127602-19-021464 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,922 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:27 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 78 | $103.38 | $8,063.64 |
DisclosureSEC source: 0001127602-19-021240 · form4.xml · nonDerivative · entry 3 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,114 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:25 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 208 | $103.38 | $21,503.04 |
DisclosureSEC source: 0001127602-19-021239 · form4.xml · nonDerivative · entry 1 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,782 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,872 | $0.00 Strike: $38.43 | $0.00 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · derivative · entry 7 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,618 Underlying: Common Stock · 4,872 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 442 | $103.38 | $45,693.96 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · nonDerivative · entry 5 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,369 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 6,745 | $103.50 | $698,107.50 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · nonDerivative · entry 4 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,811 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
Exercise / conversionCommon Stock | 4,872 | $38.43 | $187,230.96 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · nonDerivative · entry 3 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:14 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 411 | $103.38 | $42,489.18 |
DisclosureSEC source: 0001127602-19-021235 · form4.xml · nonDerivative · entry 1 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,650 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:11 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 2,834 | $103.38 | $292,978.92 |
DisclosureSEC source: 0001127602-19-021234 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,399 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:27 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,107 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001127602-19-021240 · form4.xml · derivative · entry 4 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,213 Underlying: Common Stock · 1,107 shares Expires 2024-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:27 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 1,107 | $103.25 | $114,297.75 |
DisclosureSEC source: 0001127602-19-021240 · form4.xml · nonDerivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,192 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:27 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionCommon Stock | 1,107 | $41.64 | $46,095.48 |
DisclosureSEC source: 0001127602-19-021240 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 6,148 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · derivative · entry 6 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,444 Underlying: Common Stock · 6,148 shares Expires 2024-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 6,148 | $103.25 | $634,781.00 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · nonDerivative · entry 2 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,684 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:22 UTC |
Basil Michelle LEVP and General Counsel
|
Exercise / conversionCommon Stock | 6,148 | $41.64 | $256,002.72 |
DisclosureSEC source: 0001127602-19-021236 · form4.xml · nonDerivative · entry 1 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 23, 2019 Filed May 24, 2019 20:25 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 24,412 | $99.39 | $2,426,308.68 |
DisclosureSEC source: 0001127602-19-019895 · form4.xml · nonDerivative · entry 2 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,233 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the performance share units reported above. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:25 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantCommon Stock | 53,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019895 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,645 F1 · shares: Represents shares earned from performance share unit awards granted to the reporting person on June 29, 2016 and July 26, 2017 with performance periods ending on March 30, 2019, based on achievement of 80.05% and 144.31% of their respective internal financial and performance metric targets, as certified by the Compensation Committee of the Board of Directors effective May 22, 2019. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 21, 2019 Filed May 24, 2019 20:28 UTC |
KROLL MARK WDirector
|
GiftCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019898 · form4.xml · nonDerivative · entry 1 KROLL MARK W · CIK 0001259254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,157 F1 · kind: Shares transferred as a bona fide gift without any consideration. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:17 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 48,971 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018731 · form4.xml · derivative · entry 2 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,971 Underlying: Common Stock · 48,971 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:17 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantCommon Stock | 14,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018731 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,991 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:43 UTC |
Goldstein DanVP, Corporate Controller
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 2,003 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018752 · form4.xml · derivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003 Underlying: Common Stock · 2,003 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:43 UTC |
Goldstein DanVP, Corporate Controller
|
GrantCommon Stock | 573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018752 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,192 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:37 UTC |
Llorens JosepSVP, Global Manufacturing
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,342 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018745 · form4.xml · derivative · entry 2 Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,342 Underlying: Common Stock · 5,342 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:37 UTC |
Llorens JosepSVP, Global Manufacturing
|
GrantCommon Stock | 1,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018745 · form4.xml · nonDerivative · entry 1 Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,871 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:26 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,342 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018736 · form4.xml · derivative · entry 5 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,342 Underlying: Common Stock · 5,342 shares Expires 2026-05-14 F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:26 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,299 | $0.00 Strike: $38.43 | $0.00 |
DisclosureSEC source: 0001127602-19-018736 · form4.xml · derivative · entry 4 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,599 Underlying: Common Stock · 1,299 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:26 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
GrantCommon Stock | 1,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018736 · form4.xml · nonDerivative · entry 3 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,990 F3 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The restricted stock units vest in annual increments of 25% beginning on the first anniversary of the date of grant. F4 · price: Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F5 · balance_after: This number includes unvested restricted stock units previously reported and 223 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2019. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:26 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 1,508 | $100.00 | $150,800.00 |
DisclosureSEC source: 0001127602-19-018736 · form4.xml · nonDerivative · entry 2 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,237 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:26 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
Exercise / conversionCommon Stock | 1,299 | $38.43 | $49,920.57 |
DisclosureSEC source: 0001127602-19-018736 · form4.xml · nonDerivative · entry 1 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:29 UTC |
Bolorforosh SaidEVP, Chief Technology Officer
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,451 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018739 · form4.xml · derivative · entry 2 Bolorforosh Said · CIK 0001741776 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 Underlying: Common Stock · 4,451 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:29 UTC |
Bolorforosh SaidEVP, Chief Technology Officer
|
GrantCommon Stock | 1,275 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018739 · form4.xml · nonDerivative · entry 1 Bolorforosh Said · CIK 0001741776 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,210 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:19 UTC |
Basil Michelle LEVP and General Counsel
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 9,794 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018733 · form4.xml · derivative · entry 2 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,794 Underlying: Common Stock · 9,794 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:19 UTC |
Basil Michelle LEVP and General Counsel
|
GrantCommon Stock | 2,805 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018733 · form4.xml · nonDerivative · entry 1 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,684 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:15 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 10,684 | $0.00 Strike: $98.03 | $0.00 |
DisclosureSEC source: 0001127602-19-018729 · form4.xml · derivative · entry 2 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,684 Underlying: Common Stock · 10,684 shares Expires 2026-05-14 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:15 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
GrantCommon Stock | 3,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018729 · form4.xml · nonDerivative · entry 1 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,061 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:03 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 57,587 | $94.51 | $5,442,547.37 |
DisclosureSEC source: 0001127602-19-018581 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,964 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on April 25, 2019. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported as well as 234 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2019. Read SEC document |
| April 29, 2019 Filed May 1, 2019 21:03 UTC |
Pomeroy ClaireDirector
|
GrantCommon Stock | 496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-016753 · form4.xml · nonDerivative · entry 1 Pomeroy Claire · CIK 0001603648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:09 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantCommon Stock | 131,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016241 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,317 F1 · kind: Represents shares earned from a performance share unit award granted to the reporting person on June 29, 2016, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from April 3, 2016 to March 30, 2019, as certified by the Compensation Committee of the Board of Directors on April 23, 2019. The award is subject to the reporting person's continued service through the vesting date of May 10, 2019. F2 · balance_after: This number includes unvested restricted stock units previously reported as well as 141 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2018. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 20:54 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 389 | $88.99 | $34,617.11 |
DisclosureSEC source: 0001127602-19-015179 · form4.xml · nonDerivative · entry 4 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,619 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:54 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,607 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-19-015179 · form4.xml · derivative · entry 5 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,607 Underlying: Common Stock · 2,607 shares Expires 2023-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:54 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 210 | $88.31 | $18,545.10 |
DisclosureSEC source: 0001127602-19-015179 · form4.xml · nonDerivative · entry 3 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,008 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:54 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 2,607 | $88.93 | $231,840.51 |
DisclosureSEC source: 0001127602-19-015179 · form4.xml · nonDerivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:54 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionCommon Stock | 2,607 | $34.42 | $89,732.94 |
DisclosureSEC source: 0001127602-19-015179 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units previously reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.